v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:        
Net loss $ (2,131) $ (938) $ (17,921) $ (4,301)
Adjustments:        
Depreciation expense     3 2
Stock-based compensation     302 508
Impairment of intangible assets 0 0 13,533 0
Change in fair value of derivative warrant liabilities 0 (1,427) 0 (940)
Change in deferred tax liability     (8) 0
Changes in operating assets and liabilities:        
Receivables     0 106
Prepaid expenses     (246) 37
Trade and other payables     (668) (356)
Net cash used in operating activities     (5,005) (4,944)
Cash flows from financing activities:        
Payment of stock issuance costs     (661) (327)
Gross proceeds from issuance of common stock from private placement     10,000 0
Net cash provided by (used in) financing activities     9,339 (327)
Net increase (decrease) in cash and cash equivalents     4,334 (5,271)
Cash and cash equivalents, beginning of period     16,977 22,133
Cash and cash equivalents, end of period 21,311 16,862 21,311 16,862
Cash and cash equivalents are comprised of:        
Cash 1,095 1,893 1,095 1,893
Cash equivalents $ 20,216 $ 14,969 20,216 14,969
Supplemental schedule of non-cash financing activities is comprised of:        
Issuance costs in accounts payable     $ 136 $ 0